Importantly, we validated the IGF2BP1 expression level using the IHC assay in 40 patients with BC, and IGF2BP1 represented a higher expression level in the high-circRRM2 group (Fig. 8J, K). The gene discussed is IGF2BP1; the disease is breast cancer.